Every material Form 8-K ACME UNITED CORP has filed with the SEC since July 21, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Acme United reported third-quarter 2026 net sales of $58.0 million, up 18% from $49.1 million a year earlier, with comparable sales up 10% excluding My Medic. Net income rose to $3.4 million, or $0.80 per diluted share, from $1.9 million, or $0.46, helped by a $4.0 million recognized tariff refund that was partly offset by $1.8 million of DMT facility closure costs. Shareholders get a quarter of higher sales and profit, though the company said My Medic's earnings contribution is seasonal and concentrated in the fourth quarter.
Q3 net sales $58.0 million vs. $49.1 million, up 18%; comparable sales up 10% excluding My Medic
Q3 net income $3.4 million, or $0.80 diluted EPS, vs. $1.9 million, or $0.46 a year earlier
Gross margin 45.3% vs. 39.1%, including a benefit of approximately 690 basis points from the tariff refund
Company plans to close its DMT plant in Massachusetts later this year, with annual savings expected to exceed $1.0 million in 2027
Acme United reported second-quarter 2026 net sales of $62.7 million, up 16% from $54.0 million a year earlier, and net income of $5.1 million, or $1.22 per diluted share, versus $1.16 a year earlier. Excluding sales from the My Medic acquisition, comparable quarterly sales rose 8%, and the company said My Medic had minimal impact on second-quarter earnings. For the six months, net income fell 6% to $6.0 million and diluted EPS fell 7% to $1.46, which the company attributed mainly to first-quarter results.
Q2 2026 net sales were $62.7 million versus $54.0 million, up 16%; excluding My Medic, up 8%.
Q2 2026 net income was $5.1 million, or $1.22 per diluted share, versus $4.8 million, or $1.16, a year earlier.
Six-month net income was $6.0 million, or $1.46 per diluted share, down 6% and 7% respectively from the same period in 2025.
On July 15, 2026, the company entered into a new $65 million syndicated credit facility expiring July 15, 2029.
Acme United signed a new $65 million syndicated credit facility on July 15, 2026, replacing its prior HSBC facility, which was set to expire May 31, 2027. The company says the facility is intended for growth, acquisitions, dividends and other business uses, and it runs through July 15, 2029.
New $65 million facility with HSBC Bank USA as administrative agent and City National Bank as a syndicate member
Opening balance of $28.5 million, equal to the payoff of the former HSBC facility on July 15, 2026
Pricing at Term SOFR plus 2.00%-2.75%, secured by a first-priority lien on substantially all assets, with a 3.75 to 1.00 maximum leverage covenant
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every ACME UNITED CORP filing is on SEC EDGAR ↗. 8-K briefs of other companies →